Kentucky diabetic says proposed Medicare rule could disrupt access to glucose monitor

A Kentucky diabetic who uses a glucose monitoring device to manage her condition says she is concerned a new Center for Medicare and Medicaid Services rule proposal could change how Medicare covers the technology, potentially disrupting access for patients who rely on it daily. WAVE reported Tuesday that Kaye Peterson, who has diabetes, worries that Medicare’s cost-cutting effort could affect whether she can continue getting her device and supplies through the program.

Peterson said the monitoring equipment helps her track blood sugar trends and respond to changes between appointments, and she fears any shift in coverage rules or reimbursement levels could limit options for patients. The report describes her concern that the proposed policy change could force some people to switch devices, face delays, or pay more for monitoring supplies.

WAVE said the issue is tied to Medicare’s effort to reduce program spending, with CMS proposing changes under its broader cost-control approach. The report does not describe the technical details of the proposal, such as specific coverage criteria, price adjustments, or the date it would take effect, but it frames the potential impacts around continuity of care and access to medically necessary monitoring.

The story comes as Medicare coverage decisions increasingly affect medical device access, particularly for patients who depend on consistent, long-term supplies. For people managing diabetes, the monitoring hardware and recurring sensor supplies are typically tied to ongoing treatment plans, and changes to Medicare rules can ripple through ordering practices, supplier availability, and patient budgets.

Peterson’s concerns also highlight the administrative process behind federal coverage changes. CMS typically issues proposed rules that allow for public comment before final requirements are set. If the proposal advances, Medicare beneficiaries in Kentucky could see changes after the rule is finalized and implemented, depending on how CMS structures coverage, supplier requirements, and reimbursement.

WAVE’s report also underscores that patients may be caught between federal rulemaking and day-to-day medical needs, particularly when coverage shifts before a patient has time to re-plan. While the proposal is described as a cost-cutting measure by CMS, the practical effect for individuals will depend on the final policy language and enforcement details.

At this stage, it remains unclear from the WAVE report whether Peterson or other Kentucky patients would immediately lose access, change devices, or pay different amounts, and what timelines CMS would set for implementation. If the rule is finalized, beneficiaries and caregivers are likely to look for clearer guidance from Medicare, their care teams, and the device suppliers that provide ongoing sensors and equipment.